Amelioration of Paget Disease of Bone After Denosumab for Osteopenia

Amelioration of Paget Disease of Bone After Denosumab for Osteopenia

Background/Objective: Denosumab is a monoclonal antibody that inhibits bone resorption and is indicated for the treatment of osteoporosis, bone metastases, and giant cell tumor of bone. We describe a woman with symptomatic Paget disease of the skull whose headaches and monostotic disease of the skul...

Full description

Bibliographic Details
Main Authors: Vijayvardhan Kamalumpundi, BS, Elham Shams, MD, Maisoon Torfah, MD, Marcelo L. Correia, MD, MSc, PhD
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:AACE Clinical Case Reports
Subjects:
Paget disease of bone
denosumab
bisphosphonates
bone diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S237606052300113X

Internet

http://www.sciencedirect.com/science/article/pii/S237606052300113X

Similar Items